GSK’s Blenrep Returns With Simpler REMS, But Narrower Indication Than Targeted

 
• By Andrew McConaghie
  
GSK
Administration outside the hospital is one of Blenrep's advantages in the market, GSK said.

More from Approvals

More from United States